1) Data from 131 cognitively normal older adu |
2) Data from 214 adults aged 66.5 to 92.8 yea |
3) Data from the 2019 New Mexico Youth Risk a |
4) Data from three different studies of young |
5) Public databases featuring original, raw data from "Omics" experiments enable resea |
6) atewide point-of-sale study, we collected data from 1,354 ST retailers. |
7) In total, data from 1388 lactating mothers (4011 mil |
8) We abstracted data from 16 and 11 observational and clin |
9) Gene expression data from 17,382 samples across 52 tissues |
10) Twelve studies published since 2010 with data from 18 countries identified four maj |
11) This study examined data from 264 MDD outpatients treated with |
12) We evaluated the data from 27 studies aimed to investigate |
13) In total, quantitative data from 27 studies conducted in 18 count |
14) e we leverage peripheral blood sequencing data from 32,442 cancer patients to jointl |
15) The two screeners independently extracted data from 37 eligible articles, which were |
16) Here, we utilize data from Add Health, a large, nationally |
17) l lifestyles, including novel metagenomic data from Burkina Faso (n = 90). |
18) on the application of machine learning on data from COVID-19-related social media an |
19) ry potential of VNTRs, we used read-depth data from Illumina whole-genome sequencing |
20) monthly leptospirosis and meteorological data from January 2007 to April 2019 from |
21) nd TRG were obtained by analyzing genomic data from PacBio sequencing. |
22) tronic health records and genetic biobank data from Tayside, Scotland, we examined t |
23) ctrocardiogram (ECG) waveforms to emulate data from a non-invasive wearable device. |
24) two normal distributions to progesterone data from all non-calf females to identify |
25) using exome sequencing and array genotype data from an additional 15,205 individuals |
26) h through-plane resolution CT images with data from both groups of cancer patients. |
27) Using publicly available transcriptomic data from cord blood mononuclear cells, tr |
28) scaffold for the incorporation of further data from environmental sequencing and eco |
29) tries, reflecting the need for additional data from low-middle-income countries, whe |
30) in disease areas such as psoriasis, where data from multiple clinical trials (CTs) o |
31) network meta-analysis use aggregate level data from multiple studies. |
32) In total, across all four studies, data from only 314 women were included. |
33) Finally, we analysed data from over 200,000 participants on the |
|